KRAS and cancer: Most importantly, oncogenic K-Ras contributes to EMT induction, suggesting that gene products generated from alternative splicing mediated by oncogenic K-Ras are limited in cancer cells, and differ from those produced during pathophysiological/fibrosis EMT and physiological/developmental EMT.